The short answer
Sperm can contribute to failed fertilisation and poor embryo development, so the AUA/ASRM guideline says the male partner should be evaluated after failed IVF, not only the woman 1. Sperm DNA fragmentation testing is disputed: ESHRE does not recommend it after implantation failure, but says it can be considered after recurrent pregnancy loss 3,4.
Much of the testing after a failed cycle focuses on the woman, because most of the treatment happened in her body. But half of every embryo comes from the sperm, and a semen report that was 'fine' before treatment does not answer every question about it.
This page covers what a male fertility evaluation should include after failed IVF, how to read a semen analysis under the WHO 2021 manual, what a sperm DNA fragmentation test measures, and why ESHRE, the AUA/ASRM and the UK regulator do not agree on when to use it. The treatments offered for high fragmentation are rated by what the evidence shows 1,2,3,4,5,6.
How common is this?
about 20%
Infertile couples in which a male factor is the only cause; it contributes in another 30–40% (AUA/ASRM guideline)1
about 15% vs 40%
Men with a varicocele: all adult men vs infertile men1
38.2% vs 41.9%
Live birth per first transfer when sperm DNA fragmentation was 15% or less vs above 15%, in a cohort of 1,339 women; the difference was not significant3
Reading your report
- Semen analysis (spermiogram)
- The basic test of volume, sperm concentration, total count, motility, vitality and shape. The WHO 2021 manual sets the laboratory methods 2.
- Progressive motility (PR)
- The percentage of sperm swimming forward. Total motility adds sperm that move without progressing.
- Normal forms (morphology)
- The percentage of sperm with a normal shape under strict criteria. In fertile men the figure is low; the median in the WHO reference data was 14% 2.
- Sperm DNA fragmentation (SDF), DFI
- Breaks in the DNA strands inside sperm, reported as a percentage of sperm affected. DFI (DNA fragmentation index) is the name used by some assays 2.
- TUNEL, SCSA, SCD, Comet
- Different laboratory methods for measuring DNA fragmentation. They detect different kinds of damage, so a result from one cannot be compared with a cut-off from another 2,5.
- Varicocele
- Enlarged veins in the scrotum. 'Palpable' means a doctor can feel it on examination; some are seen only on ultrasound 1.
- TESA / TESE
- Testicular sperm aspiration or extraction: taking sperm directly from the testis with a needle or small operation 1.
Likely causes, most common first
| Cause | How you'd know | Test that tells you |
|---|---|---|
| Low sperm count, motility or abnormal shape | Semen analysis. ESHRE notes these deviations are associated with low fertilisation and poor embryo development, not only with lower natural conception 3. | One or more semen analyses to WHO 2021 methods; the AUA/ASRM advises considering a second test about a month apart, especially if the first is abnormal 1,2 |
| Sperm that cannot activate the egg | Mature eggs were injected by ICSI and none or very few fertilised; round-headed sperm (globozoospermia) is one known cause 5. | Review of the embryology report; see the fertilisation failure page |
| High sperm DNA fragmentation | Only by a DNA fragmentation test. WHO notes it is partly independent of the ordinary semen result, so a normal semen analysis does not exclude it 2. | Sperm DNA fragmentation test; whether to do it is disputed between guidelines 3,4,5 |
| A chromosomal change in the male partner | Karyotype blood test. The AUA/ASRM says clinicians should consider it after failed IVF 1; ESHRE says karyotyping of both partners can be considered after repeated implantation failure 3. | Karyotype |
| Varicocele | Felt on examination by a urologist or andrologist; ESHRE lists varicocele among conditions linked with higher DNA fragmentation 5. | Physical examination by a male reproductive specialist 1 |
| Age, smoking, alcohol, weight | History. ESHRE's pregnancy-loss guideline recommends assessing these in the male partner 4; ESHRE's implantation-failure group recommends reviewing lifestyle in both partners 3. | Lifestyle review for both partners |
What did not cause this
"His semen report was normal, so the problem must be my eggs or my uterus"
The AUA/ASRM guideline notes that sperm that look normal on a semen analysis may still be chromosomally abnormal or carry DNA damage, and says the male partner should be evaluated after failed IVF 1.
"A high DNA fragmentation result proves why IVF failed"
In a cohort of 1,339 women cited by ESHRE, live birth per first transfer was 38.2% with fragmentation at or below 15% and 41.9% above it, not a significant difference 3. ESHRE's add-ons group says the test's predictive value is inconclusive 5.
"Repeated transfer failure means the sperm must be bad"
ESHRE found the link between sperm quality and implantation failure weak; one study found better sperm motility and shape in couples with implantation failure than in controls 3.
Can sperm be the reason IVF failed?
Sometimes. Sperm matter most at fertilisation and in early embryo development. ESHRE notes that abnormal sperm concentration, motility and morphology are associated with low fertilisation and poor embryo development 3, and failed egg activation, which can stem from the sperm, is a recognised cause of fertilisation failure after ICSI 5.
The link with failed transfers is weaker. ESHRE's 2023 implantation-failure recommendations describe the data linking sperm to repeated implantation failure as lacking robustness 3. So the stage at which your cycle stopped is the first clue: eggs that did not fertilise or embryos that stopped early point towards the sperm more than a failed transfer of good embryos does.
What should a male fertility evaluation include after failed IVF?
The AUA/ASRM guideline on male infertility (2020, amended 2024) says that in couples with failed ART cycles or two or more pregnancy losses, clinicians should evaluate the male partner 1. It recommends a reproductive history and one or more semen analyses, with a full history and physical examination by a male reproductive specialist when results are abnormal 1.
After failed IVF, the same guideline says clinicians should consider a karyotype and sperm DNA fragmentation testing 1. ESHRE recommends reviewing lifestyle factors in both partners once implantation failure is recognised, because habits can change during treatment 3. In practice this means seeing a urologist or andrologist, not only repeating a semen test at the IVF clinic.
How should a semen analysis be read under WHO 2021?
The WHO laboratory manual, 6th edition (2021), sets out how the test should be done and gives the distribution of results from about 3,500 men in 12 countries whose partners conceived naturally within a year 2. The table below shows the 5th centile, the level only 5% of those men were below, and the median.
WHO states plainly that the 5th centile is not a line between fertile and infertile men 2. The AUA/ASRM adds that values above or below it do not by themselves predict fertility or infertility, and that because results vary from test to test, a second analysis about a month apart is worth considering 1. Older reports may still quote the 2010 edition; the 2021 manual presents its figures as a reference distribution rather than pass or fail limits 2.
The reference data came from men in Australia, the USA, China, Egypt, Iran and seven European countries; no Indian cohort is listed in the WHO table of data sources 2.
What does a sperm DNA fragmentation test measure?
It measures the share of sperm with single- or double-strand breaks in their DNA 2. The common methods are TUNEL, the Comet assay, the sperm chromatin structure assay (SCSA) and the sperm chromatin dispersion (SCD) test; TUNEL and Comet detect breaks directly, while SCSA and SCD detect chromatin that is susceptible to damage 2.
WHO says each method has its own cut-off, which the performing lab should set and validate 2. A meta-analysis cited by ESHRE proposed 20% as a level separating infertile from fertile men 5, but that is a population average, not a validated threshold for deciding treatment.
There are practical limits too. Results change with lab conditions such as incubation time, centrifugation and freezing, and with whether the sample is ejaculated or testicular 5. The sperm tested cannot then be used, and nothing ensures that the single sperm injected in ICSI is free of breaks 5.
Why do guidelines disagree about DNA fragmentation testing?
Because they are answering different questions, and the evidence is thin for all of them.
- ESHRE, repeated implantation failure (2023): sperm DNA fragmentation testing is not recommended; there is no standard method or threshold and results conflict 3.
- ESHRE, recurrent pregnancy loss (2022): assessing sperm DNA fragmentation can be considered, for explanatory purposes and, in the 2022 update, for diagnostic purposes (a conditional recommendation) 4.
- ESHRE, add-ons (2023): not recommended for routine use; insufficient evidence that the test predicts pregnancy or should guide treatment 5.
- AUA/ASRM (2024): not recommended in the initial evaluation of an infertile couple; should be used to evaluate the male partner after recurrent pregnancy loss; may be advantageous after repeated IVF failure 1.
- HFEA (UK regulator): evidence is conflicting and depends on the test used; results are unlikely to change your treatment; no traffic-light rating 6.
What treatments are offered for high DNA fragmentation, and do they work?
Testicular sperm is the option with the most direct rationale. ESHRE notes that passage through the ducts after the testis may expose sperm to oxidative damage, so sperm taken directly from the testis may carry less 5. A meta-analysis of four observational studies (507 ICSI cycles) in men with high fragmentation reported clinical pregnancy of 50% with testicular sperm vs 29.4% with ejaculated sperm, but ESHRE notes the evidence is of moderate quality and not matched for confounders 5. The AUA/ASRM lists it as something clinicians may consider in men who are not azoospermic 1. It means a surgical procedure for the man.
Oral antioxidants are widely sold. A 2022 Cochrane review of 90 studies in 10,303 subfertile men found antioxidants may increase live birth, but the evidence was very low certainty, and when studies at high risk of bias were removed there was no evidence of benefit 9. ESHRE does not recommend antioxidant therapy in ART 5, and the AUA/ASRM calls supplements of questionable clinical utility 1.
Advanced sperm selection methods are also offered. The HFEA rates PICSI black for men having ICSI for male factor, meaning moderate or high-quality evidence shows no effect on the chance of a baby 7, and IMSI grey, meaning there is not enough good evidence to rate it 8. ESHRE does not recommend PICSI, MACS or IMSI routinely, and says microfluidic sperm sorting can be considered on the basis of one small trial 5.
No treatment for high fragmentation has been tested in couples with repeated implantation failure in studies good enough to support a recommendation 3.
Does a varicocele need surgery before the next IVF?
It depends on whether it can be felt and what the semen shows. The AUA/ASRM guideline says clinicians should consider surgery for men trying to conceive who have a palpable varicocele, infertility and abnormal semen parameters, except those with no sperm in the ejaculate 1. It advises against surgery for varicoceles seen only on imaging 1.
The trial evidence is modest and mostly not from IVF. A 2021 Cochrane review found treatment may improve pregnancy rates compared with no or delayed treatment (from 21% to between 22% and 48%, low certainty), but was uncertain whether it improves live birth 10. The couples studied were those in which the female partner had no fertility problem 10, so the results cannot be applied directly to a couple who has already needed IVF.
It depends on…
Where did your cycle stop?
Few or no eggs fertilised
Sperm function and egg activation are the leading questions; see the fertilisation failure page 5.
Embryos stopped growing before day 5
Sperm is one of several possible contributors; a full semen analysis and male evaluation are reasonable 1,3.
WHO 2021 semen reference distribution (men whose partners conceived within 12 months)
What's worth checking
- Find the semen analysis from the day of egg collection, and any earlier ones, and check the dates.
- Ask whether the lab follows the WHO 2021 manual methods 2.
- If a result was abnormal, ask for a second analysis about a month later 1.
- Ask for a referral to a urologist or andrologist for a history and physical examination 1.
- Ask whether a karyotype for both partners makes sense for your history 1,3.
- If a DNA fragmentation test is offered, ask which method is used, what the lab's cut-off is, and what you would do differently depending on the result 2,5.
- Review smoking, alcohol, weight and medicines, including any testosterone, with the doctor 1,3.
- Before paying for PICSI, IMSI, MACS or antioxidants, ask for the ESHRE recommendation and HFEA rating.
What could change next cycle
9 options, by strength of evidence
- Good evidence it helps 1
- Mixed, or some groups only 1
- Not enough studies yet 5
- Evidence says it doesn't help 2
Ratings follow the evidence reviews cited beside each option, not our opinion.
- ICSI when semen parameters are severely abnormalGood evidence it helps
ESHRE: ICSI improved fertilisation and pregnancy rates in severe male factor infertility 5.
- Testicular sperm (TESA/TESE) when DNA fragmentation is high and sperm are present in the ejaculateNot enough studies yet
Observational studies only (50% vs 29.4% clinical pregnancy) 5; AUA/ASRM: may be considered 1; no adequate studies in repeated implantation failure 3.
- Varicocele repair for a palpable varicocele with abnormal semenMixed, or some groups only
AUA/ASRM: consider 1; Cochrane: may improve pregnancy, live birth uncertain, not studied in IVF couples 10.
- Varicocele repair for a varicocele seen only on ultrasoundEvidence says it doesn't help
AUA/ASRM: should not be recommended (strong recommendation) 1.
- Oral antioxidants for the male partnerNot enough studies yet
Cochrane 2022: very low certainty; no benefit once high-risk-of-bias trials removed 9; ESHRE: not recommended in ART 5.
- Lifestyle changes (smoking, alcohol, weight)Not enough studies yet
ESHRE recommends reviewing them, but their effect on IVF outcome has not been tested in implantation failure 3; AUA/ASRM: evidence on smoking and semen is low quality 1.
- PICSI (hyaluronan-selected sperm)Evidence says it doesn't help
HFEA: black for ICSI in male factor infertility 7; ESHRE: not recommended routinely 5.
- IMSI (high-magnification sperm selection)Not enough studies yet
HFEA: grey 8; ESHRE: similar live birth to ICSI in a Cochrane review, not recommended routinely 5.
- MACS or microfluidic sperm sortingNot enough studies yet
ESHRE: MACS not recommended; microfluidics can be considered on one small trial 5.
Questions to ask your doctor
- Has my partner had a full male fertility evaluation, or only a semen analysis?
- Was the semen analysis done to WHO 2021 methods, and should it be repeated?
- Given where our cycle stopped, is a DNA fragmentation test likely to change what you do next?
- If the result is high, which treatment would you offer, and what is the evidence for it in couples like us?
- Is a varicocele present, and is it one that guidelines would treat?
- Would you suggest karyotyping for both of us?
Questions people ask
Can sperm DNA fragmentation be reduced before the next cycle?
Several approaches are tried, including stopping smoking, varicocele repair and a short abstinence interval, but ESHRE found no studies of sufficient quality testing them in couples with implantation failure 3, and the AUA/ASRM found no well-controlled studies showing they lower miscarriage risk 1. The AUA/ASRM suggests discussing lifestyle change, varicocele repair and microfluidic sperm processing with couples who have high fragmentation 1.
Does the man's age affect IVF success?
Should we use donor sperm after failed IVF?
Does a normal DNA fragmentation result mean the sperm is fine?
How many days should he avoid ejaculating before the semen test?
The WHO manual says the sample should be produced after a minimum of 2 days and a maximum of 7 days without ejaculating 2. WHO also notes that this window rests on clinical experience rather than trials and itself adds variability to results, and that sperm vitality and chromatin are not affected by a longer gap unless the epididymis is diseased 2.
His morphology is 2%. Does that mean IVF will not work?
One low value does not predict that. WHO's reference distribution puts 4% normal forms at the 5th centile of men whose partners conceived naturally within a year, and presents it as a distribution rather than a pass mark 2. The AUA/ASRM guideline says no single parameter is diagnostic of infertility apart from a few specific conditions, and that one abnormal parameter carried an odds ratio of about 2.5 1.
Do hot baths, laptops, tight underwear or mobile phones damage sperm?
Nobody has shown that they do. In the AUA/ASRM evidence review, no systematic review met the inclusion criteria for heat exposure or type of underwear, so there is no usable evidence either way, and mobile phones showed no impact on low-quality evidence 1. Smoking is the habit with the clearest link, though that evidence is also low quality 1.
He is taking testosterone injections or gym supplements. Could that matter?
Testosterone matters a great deal. The AUA/ASRM guideline states that clinicians should not prescribe exogenous testosterone to a man who wants current or future fertility, and that ongoing anabolic steroid use suppresses sperm production and interferes with fertility, with low-quality evidence suggesting the effect is not permanent 1. Tell the fertility doctor about anything he takes, including gym products.
He had a fever a few weeks before the cycle. Could that have affected the sperm?
It can. WHO lists recent illness, particularly a febrile one, among the things ejaculate characteristics depend on, and says such factors should be recorded and taken into account when the result is interpreted 2. Its standard report form asks about severe infection or inflammatory disease in the previous six months 2. Mention any illness when the sample is given.
His report mentions pus cells. Does that mean an infection?
Not by itself. The AUA/ASRM guideline says that when round cells exceed 1 million per millilitre, the laboratory should work out whether they are white blood cells or immature germ cells, because the two look similar down a microscope 1. If white cells are confirmed, the guideline says the man should then be evaluated for infection 1.
His sperm count is under 1 million. Should he have genetic tests?
The AUA/ASRM guideline recommends a karyotype for men with no sperm or under 5 million per millilitre when there is also a raised FSH, small testes or evidence of impaired sperm production, and Y-chromosome microdeletion analysis at 1 million or below in the same situation 1. Microdeletions are found in 3% to 7% of men with severe oligospermia, and a son can inherit one 1.
The report says no sperm at all. Is IVF still possible?
Often, yes. The AUA/ASRM guideline says azoospermia should first be worked up to separate a blockage from failed sperm production, using examination, semen volume, semen pH and FSH 1. Where production has failed and sperm retrieval is attempted, it recommends microdissection testicular sperm extraction, and ICSI may use fresh or frozen retrieved sperm 1.
Sources
- American Urological Association / American Society for Reproductive Medicine. Diagnosis and treatment of infertility in men: AUA/ASRM guideline (2020; amended 2024). Brannigan RE, Hermanson L, Kaczmarek J, et al. Updates to male infertility: AUA/ASRM guideline (2024). J Urol. 2024. AUA / ASRM
- World Health Organization. WHO laboratory manual for the examination and processing of human semen, 6th edition. Geneva: WHO; 2021. WHO
- ESHRE Working Group on Recurrent Implantation Failure; Cimadomo D, de los Santos MJ, Griesinger G, et al. ESHRE good practice recommendations on recurrent implantation failure. Hum Reprod Open. 2023;2023(3):hoad023. ESHRE / Human Reproduction Open
- ESHRE Guideline Group on RPL; Bender Atik R, Christiansen OB, Elson J, et al. ESHRE guideline: recurrent pregnancy loss: an update in 2022. Hum Reprod Open. 2023;2023(1):hoad002. ESHRE / Human Reproduction Open
- ESHRE Add-ons working group; Lundin K, Bentzen JG, Bozdag G, Ebner T, Harper J, et al. Good practice recommendations on add-ons in reproductive medicine. Hum Reprod. 2023;38(11):2062–2104. ESHRE / Human Reproduction
- Human Fertilisation and Embryology Authority. Sperm DNA damage (treatment add-ons information page; published 12 August 2020). HFEA (UK regulator)
- Human Fertilisation and Embryology Authority. Physiological intracytoplasmic sperm injection (PICSI) (treatment add-ons rating page). HFEA (UK regulator)
- Human Fertilisation and Embryology Authority. Intracytoplasmic morphologic sperm injection (IMSI) (treatment add-ons rating page). HFEA (UK regulator)
- de Ligny W, Smits RM, Mackenzie-Proctor R, Jordan V, Fleischer K, de Bruin JP, Showell MG. Antioxidants for male subfertility. Cochrane Database Syst Rev. 2022;5(5):CD007411. Cochrane
- Persad E, O'Loughlin CA, Kaur S, Wagner G, Matyas N, Hassler-Di Fratta MR, et al. Surgical or radiological treatment for varicoceles in subfertile men. Cochrane Database Syst Rev. 2021;4(4):CD000479. Cochrane